INTRODUCTION
Ventricular septal defect (VSD) is one of the most common congenital heart diseases [1] . Although closure of VSD using a percutaneous transcatheter device has proved to be a valuable alternative in selected patients, it was nonetheless associated with several adverse effects, such as arrhythmia, vascular complications and injury to the tricuspid or aortic valve. With advances in surgery, perfusion and cardiology, and the invention of minimally invasive devices, several strategies of minimally invasive surgery have been developed. One such strategy is to use a minor incision to ensure a more favourable cosmetic result, such as ministernotomy, anterolateral thoracotomy, right infra-axillary thoracotomy or totally endoscopic surgery [2] ; the other is transthoracic device closure (TTDC) of VSD, developed only recently, which could avoid cardiopulmonary bypass (CPB) as well as achieve the desired cosmetic effects [3] .
In Daping Hospital of the Third Military Medical University (Chongqing, China), most restrictive perimembranous VSD patients accepted minimally invasive surgery in the form of surgical repair with right infra-axillary thoracotomy (SRRIAT) or TTDC. There are many reports comparing various minimally invasive approaches for VSD repair with standard median sternotomy, yet few have been published to compare these two minimally invasive approaches. Hence, the purpose of this study was to assess the baseline characteristics of patients undergoing minimally invasive surgery for perimembranous VSD, and compare the outcomes of and complications from SRRIAT and TTDC.
To accurately compare the results of these two approaches, the patients who met the following criteria were included: (i) perimembranous VSD, (ii) no aortic regurgitation, (iii) accepting SRRIAT or TTDC, (iv) maximum VSD diameter ≤10 mm and (v) no associated cardiac anomalies besides patent foramen ovale (PFO). The present clinical study was approved by the Clinical Research Ethics Committee of Daping Hospital, Third Military Medical University.
Details regarding age, sex, weight, VSD diameter, operation duration, drainage volume, mechanical ventilation, hospital stay, total cost, CPB time, aortic cross-clamping time, use of blood products, both early and late outcomes and stay in the intensive care unit (ICU), were abstracted from a retrospective review of clinical notes, surgical protocols and imaging study reports. The follow-up assessments were done at approximately 1, 6 and 12 months postsurgery in the first year and yearly thereafter.
Minimally invasive surgical repair with right infra-axillary thoracotomy
To perform SRRIAT, patients were positioned in a left lateral decubitus position. The right arm was put over the head, with the shoulder joint abducted at 120°. The incision was made from the second to the fifth intercostal space along the right midaxillary line (Fig. 1A) . After entrance into the thoracic cavity through the fourth intercostal space using two orthogonal retractors, the pericardium was exposed by retracting the lung posteriorly. The pericardium was opened 2 cm anterior to the phrenic nerve, superiorly to the pericardial reflection and inferiorly to the diaphragmatic level. With the pericardium retracted and a few stitches placed around the thoracic incision to keep it in place, the operative field was exposed nearly as well as that in standard median sternotomy (Fig. 1B) . Cannulae were placed in the ascending aorta, superior vena cava and inferior vena cava (Fig. 1C) . The blood flow rate during CPB was maintained at 2.4-2.8 l/min/m 2 with a mean arterial pressure of ≥40-60 mmHg using a centrifugal pump (MaQuet Rotaflow, Mahwah, NJ, USA). Del Nido cardioplegia solution was administered as a single dose at 15 ml/kg antegrade. VSD was repaired directly or by using a Dacron patch with horizontal pledgeted mattress sutures. The sutures near the posteroinferior rim of VSD should be away from the His bundle region, and placed superficially in the septum on the right ventricular surface to avoid injury to the conducting system. Concomitant PFO closure was performed where indicated. After the completion of VSD repair, the thoracotomy was closed normally and a single right pleural drain was inserted (Fig 1D) .
Transthoracic device closure of ventricular septal defect TTDC of VSD was performed under general anaesthesia and guidance by intraoperative real-time transoesophageal echocardiography (TOE) using the Philips iE33 (Philips Medical Systems, Andover, MA, USA) imaging system. The surgery required only a short incision in the lower sternum (2-3 cm long, Fig. 2A ). After exposure of the right ventricle ( Fig. 2B ) and heparinization (1.0 mg/kg), the location of the puncture on the free wall of the right ventricle was determined by pinning the right ventricle towards the defect guided by TOE. A purse-string suture was placed, and the free wall of the right ventricular was punctured using an 18F Introcan Safety IV catheter (B. Braun Medical, Inc., Shanghai, China). A floppy guidewire was then inserted and advanced through VSD into the left ventricle, and a delivery sheath was advanced along the wire into the left ventricle under TOE guidance (Fig. 2C ). The VSD occluder (Lifetech Scientific Co., Ltd, Shenzhen, China, Fig. 2D ), a self-expandable double-disc device, was loaded onto the delivery cable, introduced into the delivery sheath and advanced to the tip of the sheath. The left disc of the occluder was expanded in the left ventricle, after which the entire instrument was gently pulled back and the left disc was closed to the ventricular septum. The sheath was then gently pulled back to allow the right disc of the occluder to expand. Before release, the position of the occluder discs and the potential impingement of the device on adjacent cardiac structures were carefully evaluated, including assessment of a residual shunt, aortic regurgitation and atrioventricular valve function. After full evaluation, the occluder devices were unscrewed for release, the sheath and delivery cables were withdrawn and the purse-string suture was tied and trimmed ( Fig 3A-F) .
The occluder was chosen according to the largest diameter of VSD and thickness of the septum, allowing for a margin of from 1 to 2 mm in excess of the waist diameter. Both asymmetric and symmetric occluders were used. The asymmetric occluder is used for defects with a <2-mm rim under the aortic valve, in which the left disc extends towards the apex and no superior margin extends towards the aorta. The symmetric occluder is used for defects with a ≥2-mm rim under the aortic valve. All patients were routinely maintained on an aspirin regimen (3-5 mg/kg daily) or equivalent antiplatelet therapy for 6 months.
Statistical analysis
Efficacy analysis of TTDC was conducted on an intent-to-treat basis, as defined by the treatment assignment group, whereas safety analysis was performed only on the data from patients who actually received TTDC, a strategy that is commonly used in large clinical trials [4] .
Categorical variables were presented as frequencies and percentages, and differences in the normally and non-normally distributed categorical variables were determined using the χ 2 and KruskalWallis tests, respectively. Continuous variables were presented as means ± standard deviations, and differences in the normally and non-normally distributed continuous variables were determined using Student's t-test and the non-parametric Mann-Whitney U-test, respectively. Statistical analyses were performed using IBM SPSS Statistics 19.0 (SPSS, Inc., Chicago, IL, USA). P < 0.05 was considered statistically significant.
RESULTS
Among the 33 patients attempting TTDC, 30 (91%) were successfully treated. Three patients failed TTDC because of not being able to pass the device through VSD, impingement of the aortic valve or obstruction of the right ventricular outflow tract. These patients were converted immediately to surgical repair with inferior partial sternotomy and subsequently excluded for further safety analysis of the TTDC group. There were 96 patients who accepted SRRIAT, among whom 20 of them accepted combined PFO closure. No difference was found in age, sex, weight or VSD diameter between the TTDC and SRRIAT groups.
Operation duration for the TTDC group was significantly shorter than that of the SRRIAT group (115.8 ± 43.8 vs 175.6 ± 41.3 min, P < 0.01). In the SRRIAT group, CPB time and aortic cross-clamping time were 72.4 ± 26.9 and 33.2 ± 21.3 min, respectively. In the TTDC group, most procedures were successfully performed on the first attempt; only 3 cases required 2-4 attempts. The rim of VSD was 3.1 ± 1.3 mm under the aortic valve and 4.6 ± 3.4 mm under the tricuspid valve. VSD occluders ranged from 5 to 12 mm ( Table 1) .
The total perioperative drainage in the TTDC group was significantly less than that in the SRRIAT group. Similarly, the volume of red blood cells used in the TTDC group was significantly less. Only 5 cases of TTDC received blood transfusions at the onset of the new surgery. There were no differences in white blood cell counts or percentages of neutrophil granulocytes on the first 3 days postoperatively (Table 1) .
Mechanical ventilation time and ICU stay for TTDC patients were significantly shorter than those of SRRIAT patients. As a consequence, the total hospital stay of the TTDC patients was also 
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shorter; however, the TTDC costs were slightly higher than those of SRRIAT (40270.6 ± 2741.3 renmingbi [RMB] vs 32964.5 ± 8221.6 RMB, P < 0.01), in which the occluder and delivery system amount to 20 000 RMB ( Table 1) .
The median follow-up duration was 20 months (from 12 to 30 months). There was no perioperative or late death during the follow-up in either group. No residual shunt was found in the TTDC group, which was evaluated before and after releasing the occluder intraoperatively, on the first day postoperatively, and during the follow-up. One patient in the SRRIAT group had a large residual shunt (3 mm) and accepted reoperation through median sternotomy 6 months later. No complete atrioventricular block (AVB) was found in either group. Right bundle branch block occurred in 2 cases of SRRIAT. Transient sinus or supraventricular arrhythmia occurred in 9 cases of TTDC and 10 cases of SRRIAT but all were reversed to sinus rhythm within 48-72 h after surgery. In addition, 1 case of SRRIAT had a wound complication. No reoperation for postoperative bleeding or other complications needing intervention were found in either group (Table 2) .
DISCUSSION
In this study, both TTDC and SRRIAT were found to exhibit excellent outcomes and cosmetic appearance for suitable VSD candidates. Compared with SRRIAT, TTDC had the advantages of short operation duration, ICU stay and hospital stay, although the costs were slightly higher because of the occluder and delivery system.
After the first report of closure for muscular VSD in a baby using an intraoperative periventricular device without CPB under echocardiography guidance [5] , many physicians have attempted the method to treat various kinds of VSD with a modified occluder and delivery system [6] [7] [8] [9] . The technique has many distinct advantages, such as avoiding long-exposure to radiation, sparing the need for CPB and its comorbidities, breaking off limitations in a patient's age and weight and being convenient for converting to a standard full sternotomy. In China, periventricular VSD device closure without CPB has gained increasing acceptance in recent years [10] [11] [12] [13] , and has become a minimally invasive alternative to traditional surgery in addition to SRRIAT. While most researchers reported only the results of TTDC or compared the outcomes of TTDC with those of VSD repair through standard full sternotomy [14] , there has been no comparison of TTDC with SRRIAT. In our cohort, both TTDC and SRRIAT were found to be safe and effective alternatives, as previously reported [2, [10] [11] [12] [13] .
AVB is a severe complication of TTDC. In 1643 cases of perimembranous VSD accepting TTDC in 10 Chinese institutions between 2010 and 2012, complete AVB occurred in 15 patients (0.75%). In 13, it occurred in the first week after operation, in 1 after 3 months and in 1 after 6 months, and only 5 cases returned to a normal heart rhythm after 3-5 days of corticosteroid treatment. The remaining patients were reopened, the device was removed and the VSD repaired using conventional methods. In all patients, arrhythmia resolved [3] . A fatal complete AVB occurred at only a very low rate of ≤3%. In our study, there was no AVB but there were 9 cases of transient sinus and supraventricular arrhythmia, which recovered spontaneously in 48-72 h postoperatively. Complication rate of complete AVB of TTDC in this study was much lower than that of percutaneous transcatheter VSD closure reported. One reason is that TTDC requires only a short pathway and an easily controllable set. The guidewire and sheath crossed the VSD vertically, and the device was deployed in a single try in most circumstances, without repeating the manoeuvre or ribbing the tissues near the conductive bundles around the VSD. In addition, most of our cases were restrictive VSDs, and the occluders were often no more than 2 mm larger than the VSD diameter.
TTDC could significantly decrease or even avoid blood loss. Initially, transfusion was needed in only 5 cases. One possible reason was the long operation time as the surgeons were inexperienced. The other reason was that the heparin was not neutralized because of a fear of thrombosis at the onset. Now, according to Chinese Expert Consensus on TTDC of VSD [15] , protamine sulphate is given to reverse the initial heparin dose at a 1:1 ratio after closure of the ventricular puncture, and then antiplatelet therapy is given 6 h after TTDC and maintained for 6 months. Considering the possibility of converting to traditional VSD repair with CPB, it is still necessary to prepare plenty of blood in the event that a transfusion is needed.
In the future, as there is further development of techniques, delivery systems and occluders, the indications for using TTDC will be expanded. It has not only been used in patients with perimembranous VSD, any kind of muscular VSD, postoperative residual shunt, post-traumatic and postinfarction VSD [16] , but also was attempted in patients with doubly committed sub-arterial VSD [13] or as part of complex hybrid cardiac surgery [17] . In addition, technological advances would make TTDC more accurate and less invasive with less postoperative complications. With the adjunctive use of a robotic system, partial median sternotomy and CPB could be avoided, which would further decrease overall tissue injury and morbidity [9] . Lim et al. [18] reported percutaneous transthoracic direct cardiac puncture in patients with prosthetic mechanical valves to perform VSD closure. They believed that selective coronary angiography before the procedure had to be performed to avoid injury to a significant marginal or left anterior coronary branch, and that a surgically scarred pericardium was important for homeostasis after ventricular puncture. Ratnayake et al. confirmed the feasibility of closed-chest transthoracic VSD closure guided by real-time magnetic resonance imaging (MRI). Importantly, real-time MRI depicted structures that were, in context, qualitatively superior to X-ray and ultrasound guidance during conventional non-surgical structural heart procedures. Absorbable collagen vascular closure devices were used to close the free wall of the right ventricle; however, the clinical translation would require further development of titanium microscrews, assurance of no heating during MRI and adjunctive catheter tools [19] .
Limitations
Although this study provides some valuable insights into the advantages and disadvantages of two minimally invasive approaches, it has a few notable limitations. First, this represents a single institutional experience with a small sample size. Secondly, it was a retrospective study, reporting the operative experience of six surgeons with an uneven distribution of cases (the TTDC procedure was performed by only three surgeons). With more cases of TTDC and SRRIAT, these limitations could be overcome.
CONCLUSIONS
Both TTDC and SRRIAT showed excellent outcomes and cosmetic appearance for suitable VSD candidates. Although its costs were higher, TTDC had the advantages over SRRIAT of a short operation duration and ICU stay, and fewer days in the hospital.
